Recce Pharmaceuticals Ltd (ASX:RCE)
0.440
-0.020 (-4.35%)
Mar 9, 2026, 2:00 PM AEST
18.92% (1Y)
| Market Cap | 133.02M |
| Revenue (ttm) | 974.56K |
| Net Income (ttm) | -30.25M |
| Shares Out | 289.18M |
| EPS (ttm) | -0.11 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 86,193 |
| Average Volume | 72,303 |
| Open | 0.450 |
| Previous Close | 0.460 |
| Day's Range | 0.440 - 0.455 |
| 52-Week Range | 0.275 - 0.730 |
| Beta | 0.20 |
| RSI | 28.36 |
| Earnings Date | Feb 26, 2026 |